Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections-Reference-Cited by-同舟云学术

Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections

Published:2015-04-03 Issue:4 Volume:43 Page:473-481
ISSN:0300-8126
Container-title:Infection
language:en
Short-container-title:Infection

Author:

Curis Emmanuel,Pestre Vincent,Jullien Vincent,Eyrolle Luc,Archambeau Denis,Morand Philippe,Gatin Laure,Karoubi Matthieu,Pinar Nicolas,Dumaine Valérie,Van Jean-Claude Nguyen,Babinet Antoine,Anract Philippe,Salmon Dominique

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s15010-015-0773-y.pdf

Reference40 articles.

1. LaPlante KL, Leonard SN, Andes DR, Craig WA, Rybak MJ. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrob Agents Chemother. 2008;52:2156–62.

2. Klepser ME, Nicolau DP, Quintiliani R, Nightingale CH. Bactericidal activity of low-dose clindamycin administered at 8- and 12-hour intervals against Staphylococcus aureus, Streptococcus pneumoniae, and Bacteroides fragilis. Antimicrob Agents Chemother. 1997;41:630–5.

3. Zabransky RJ, Johnston JA, Hauser KJ. Bacteriostatic and bactericidal activities of various antibiotics against Bacteroides fragilis. Antimicrob Agents Chemother. 1973;3:152–6.

4. Klepser ME, Banevicius MA, Quintiliani R, Nightingale CH. Characterization of bactericidal activity of clindamycin against Bacteroides fragilis via kill curve methods. Antimicrob Agents Chemother. 1996;40:1941–4.

5. Panzer JD, Brown DC, Epstein WL, Lipson RL, Mahaffey HW, Atkinson WH. Clindamycin levels in various body tissues and fluids. J Clin Pharmacol New Drugs. 1972;12:259–62.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of clindamycin concentrations in human plasma and jawbone tissue in patients with osteonecrosis of the jaw: A prospective trial;Journal of Cranio-Maxillofacial Surgery;2024-03

2. What clindamycin dose should be administered by continuous infusion during combination therapy with rifampicin? A prospective population pharmacokinetics study;Journal of Antimicrobial Chemotherapy;2023-10-26

3. Assessment of in vitro antimicrobial activity of clindamycin metabolites against Staphylococcus species;Clinical Microbiology and Infection;2023-10

4. Pharmacokinetic interaction between rifampicin and clindamycin in staphylococcal osteoarticular infections;International Journal of Antimicrobial Agents;2023-08

5. Quantification of vancomycin and clindamycin in human plasma and synovial fluid applying ultra-performance liquid chromatography tandem mass spectrometry;Journal of Chromatography B;2022-12